This NCCN-developed satellite symposium presents a great opportunity for healthcare professionals to interact with experts to be fully informed on the latest treatment advances in chronic lymphocytic leukemia (CLL). During the live event, the faculty will give an overview of recent clinical advances impacting today’s clinic along with emerging therapeutics in CLL. The symposium will also feature review of the latest updates to the NCCN Guidelines to help guide clinical application based on consensus recommendations and perspectives on emerging data. Data and guideline review will be complemented by panel discussions of various patient case scenarios with expert recommendations and supporting clinical data. NCCN Guidelines for Patients and PowerPoint slides outlining guideline recommendations will be made available to all in attendance. New developments on the near future horizon, including the utility of measurable residual disease and ongoing clinical trials of promising investigational approaches such as CAR T-cell therapy, will also be discussed. Text your questions directly to the panelists, and, throughout the program, the experts will take time to answer audience questions in order to provide their clinical approach, perspective, and interpretation of how the available clinical data should be applied to practice.